LBR

LB Pharmaceuticals Inc Common Stock (LBRX) Q1 2026 Earnings

LBRX·Reported May 12, 2026·Before market open

Diluted EPS came in at $-0.67, beat the $-0.75 consensus by $0.08.

Diluted EPS
$-0.67beat by $0.08
Consensus: $-0.75
SEC

SEC Filings

Earnings release8-K · 0001193125-26-219529
Quarterly report10-Q · 0001193125-26-219607

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about LB Pharmaceuticals Inc Common Stock's Q1 2026 earnings report.

LB Pharmaceuticals Inc Common Stock (LBRX) reported Q1 2026 earnings on May 12, 2026 before market open.

LB Pharmaceuticals Inc Common Stock reported diluted EPS of $-0.67 for Q1 2026.

EPS beat the consensus estimate of $-0.75 by $0.08.

You can read the 8-K earnings release (0001193125-26-219529) and the 10-Q periodic report (0001193125-26-219607) directly on SEC EDGAR. The filing index links above go to sec.gov.